Literature DB >> 6588920

Bioactivity of imipenem as a function of medium, time, and temperature.

E J Baron, J A Hindler.   

Abstract

The bioactivity of imipenem at 20 micrograms/ml in various agar and broth media which are commonly used in susceptibility test assays was measured at different storage temperatures over time. Imipenem was found to be more stable at 4 degrees C than at -20 degrees C and least stable in all media at 35 degrees C.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6588920      PMCID: PMC185643          DOI: 10.1128/AAC.25.6.781

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Microbiological diffusion assay II: design and applications.

Authors:  F Kavanagh
Journal:  J Pharm Sci       Date:  1975-07       Impact factor: 3.534

2.  MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Authors:  H Kropp; J G Sundelof; J S Kahan; F M Kahan; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

3.  Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.

Authors:  D L Cohn; L G Reimer; L B Reller
Journal:  J Antimicrob Chemother       Date:  1982-03       Impact factor: 5.790

  3 in total
  14 in total

1.  External factors affecting imipenem performance in dried microdilution MIC plates.

Authors:  R Grist
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  False resistance to imipenem with a microdilution susceptibility testing system.

Authors:  E J O'Rourke; K G Lambert; K C Parsonnet; A B Macone; D A Goldmann
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

3.  Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

Authors:  Lisa R McTaggart; Jennifer Doucet; Maria Witkowska; Susan E Richardson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.

Authors:  J L Staneck
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

5.  Degradation kinetics of imipenem in normal saline and in human serum.

Authors:  D J Swanson; C DeAngelis; I L Smith; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Erythromycin bioactivity is stable in ophthalmic ointment used for prophylaxis of neonatal gonococcal conjunctivitis.

Authors:  M G Bialer; E J Baron; R G Harper
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

7.  Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C.

Authors:  P L Turgeon; C Desrochers
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  Discrepancies in susceptibility test results for imipenem employing different in vitro test methods and DIN 58,940 breakpoints.

Authors:  H Grimm; C Hauss; A C Rodloff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

9.  Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem.

Authors:  J S Daly; R A Dodge; R H Glew; D T Soja; B A DeLuca; S Hebert
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 10.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.